Characterization of all possible single-nucleotide change caused amino acid substitutions in the kinase domain of Bruton tyrosine kinase.

Jouni Väliaho, Imrul Faisal, Csaba Ortutay, C I Edvard Smith, Mauno Vihinen

Journal: Human mutation 2016;36(6):638-47

PMID: 25777788

Abstract

Knowledge about features distinguishing deleterious and neutral variations is crucial for interpretation of novel variants. Bruton tyrosine kinase (BTK) contains the highest number of unique disease-causing variations among the human protein kinases, still it is just 10% of all the possible single-nucleotide substitution-caused amino acid variations (SNAVs). In the BTK kinase domain (BTK-KD) can appear altogether 1,495 SNAVs. We investigated them all with bioinformatic and protein structure analysis methods. Most disease-causing variations affect conserved and buried residues disturbing protein stability. Minority of exposed residues is conserved, but strongly tied to pathogenicity. Sixty-seven percent of variations are predicted to be harmful. In 39% of the residues, all the variants are likely harmful, whereas in 10% of sites, all the substitutions are tolerated. Results indicate the importance of the entire kinase domain, involvement in numerous interactions, and intricate functional regulation by conformational change. These results can be extended to other protein kinases and organisms.

© 2015 WILEY PERIODICALS, INC.

Address: BioMediTech, University of Tampere, Tampere, Finland.; BioMediTech, University of Tampere, Tampere, Finland.; Present address is HiDucator Ltd., Erämiehentie 2 E 22, Kangasala FI-36200, Finland.; Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden.; BioMediTech, University of Tampere, Tampere, Finland.; Department of Experimental Medical Science, Lund University, Lund, Sweden.; Research Unit, Tampere University Hospital, Tampere, Finland.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.